Provided By GlobeNewswire
Last update: Oct 20, 2025
CLEVELAND, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced the appointment of James A. Gow, MD, MBA, MS, MHCM, as the Senior Vice President, Head of Clinical Development & Medical Affairs, effective immediately.
Read more at globenewswire.comNASDAQ:ABEO (10/31/2025, 2:20:50 PM)
4.86
-0.22 (-4.33%)
Find more stocks in the Stock Screener



